Skip to main content
Metal–organic framework

Metal–organic framework

Search complete. 18 mentions across 11 episodes found for "Metal–organic framework".

Sep 21, 2026

Lance MartinHOST
7:02
They argued the structure is not a necklace of separate little metal beads.
Lance MartinHOST
7:07
It is an extended metal organic framework, a MOF, the kind of material human chemists build in labs for storage, separation, catalysts, electronics, the kind whose inventors were just handed a Nobel Prize.
Lance MartinHOST
7:21
If the claim holds, this is the first known MOF grown by an organism, not cooked in a flask, grown in mud.
Lance MartinHOST
7:30
Conductivity numbers depend on what you measure.
Lance MartinHOST
7:32
Whole fibers have been clocked at values that already embarrass most biological materials.
CraigCORRESPONDENT
15:29
Work by a Victoria University researcher may prove the country's next big gas reserve has already been discovered, and it lies in the national dairy herd.
CraigCORRESPONDENT
15:37
Dr Luke Liu works in a relatively new and emerging field as a materials chemist, combining the likes of conventional metals with organic compounds to create metal organic frameworks, or MOFs.
CraigCORRESPONDENT
15:49
Dr Liu says metal organic frameworks could prove an effective harvesting tool for New Zealand's abundant dairy cow methane supply.
CraigCORRESPONDENT
15:56
Total dairy herd emissions are about 17 million tonnes a year in New Zealand, but leu maintains a significant portion could be captured in the farm dairy at milking, with the right MOF technology in place.
Jennifer ChayesGUEST
26:27
And we worked also with my husband, Christian Borgs, and with other people.
Jennifer ChayesGUEST
26:33
And when ChatGPT came out, we asked, "Could we synthesize these amazing materials that Omar had created 30 years earlier called MOFs, metal organic frameworks? Could we synthesize them faster?" Metal organic frameworks are the most porous materials known to man.
Jennifer ChayesGUEST
27:00
A gram has the internal surface area, 'cause it's so porous, of a football field.
Jennifer ChayesGUEST
27:07
So they can do amazing things.
Marnie ChestertonHOST
42:35
So each week on this show, I'm given a personal pick, so that's the chance to tell any story that I'd like to with the help of the bottomless well of the BBC's audio archives.
Marnie ChestertonHOST
42:46
So digging around in there from last year and a Science in Action episode, they did a show about the Nobel Prize winners and winning the Nobel Prize for chemistry, here's Omar Yaghi explaining MOF or metal organic framework, his prize-winning material.
Immy HarperCORRESPONDENT
43:09
They're extremely porous.
Immy HarperCORRESPONDENT
43:10
In, in one gram of such material, uh, you could have the footage of, you know, 10, 20 apartments, or you could say more than a football field.
Hashem ArouziSOUNDBITE_SPEAKER
44:45
It's a complete step change in technology to how it's been done previously.
Hashem ArouziSOUNDBITE_SPEAKER
44:51
Basically, dehumidification machines that use dew point/refrigeration technology, which has been around for 60, 70 years, but those, uh, machines are very limited in the environments in which they can operate.
Hashem ArouziSOUNDBITE_SPEAKER
45:08
By using MOFs, we've managed to open up a huge part of the world, which is typically more arid and hotter, where those traditional machines don't work and ours does.
Marnie ChestertonHOST
45:22
And I think the, the key component for this is something I saw earlier at your R&D labs, and it, it looks a lot like washing powder, right?
Max WellingGUEST
10:18
And so what we can do is we can now, uh, basically come up with an entirely new molecule for a very specific task, and then make it in the lab, and then use that for that, for that particular task.
Max WellingGUEST
10:30
Um, I should say CUSP is not only working on MOFs.
Max WellingGUEST
10:33
In fact, this was just the first set of molecules that we worked with.
Max WellingGUEST
10:37
Uh, we have hence expanded, um, to semiconductors.
Oluwatosin GojeGUEST
62:00
We talked about what is emerging and what is on the horizon.
Oluwatosin GojeGUEST
62:06
Preclinical and emerging approaches to VVC includes the use of vaccines, biofilm disrupting agents, niclosamide nanoparticles, pH-responsive MOFs, designed antimicrobial peptides, and molecular resistance testing.
Oluwatosin GojeGUEST
62:28
Suffice to say here that because of the burden financially, mentally, and psychosocial of VVC and recurrent VVC, there are emerging clinical therapies on the horizon, especially in patients who feel the azole that are the first-line therapy.
Oluwatosin GojeGUEST
62:51
So in summary for Module 5, We conclude by saying that azole resistance is multifactorial.
Oluwatosin GojeGUEST
61:51
We talked about what is emerging and what is on the horizon.
Oluwatosin GojeGUEST
61:57
Preclinical and emerging approaches to VVC includes the use of vaccines, biofilm-disrupting agents, niclosamide nanoparticles, pH-responsive MOFs, designed antimicrobial peptides, and molecular resistance testing.
Oluwatosin GojeGUEST
62:19
Suffice to say here that because of the burden financially, mentally, and psychosocial of VVC and recurrent VVC, there are emerging clinical therapies on the horizon, especially in patients who fail the azole that are the first-line therapy.
Oluwatosin GojeGUEST
62:42
So in summary, for module five, we conclude by saying that azole resistance is multifactorial.
Oluwatosin GojeGUEST
62:00
We talked about what is emerging and what is on the horizon.
Oluwatosin GojeGUEST
62:06
Preclinical and emerging approaches to VVC includes the use of vaccines, biofilm disrupting agents, niclosamide nanoparticles, pH-responsive MOFs, designed antimicrobial peptides, and molecular resistance testing.
Oluwatosin GojeGUEST
62:28
Suffice to say here that because of the burden financially, mentally, and psychosocial of VVC and recurrent VVC, there are emerging clinical therapies on the horizon, especially in patients who feel the azole that are the first-line therapy.
Oluwatosin GojeGUEST
62:51
So in summary for Module 5, We conclude by saying that azole resistance is multifactorial.
Oluwatosin GojeGUEST
62:00
We talked about what is emerging and what is on the horizon.
Oluwatosin GojeGUEST
62:06
Preclinical and emerging approaches to VVC includes the use of vaccines, biofilm disrupting agents, niclosamide nanoparticles, pH-responsive MOFs, designed antimicrobial peptides, and molecular resistance testing.
Oluwatosin GojeGUEST
62:28
Suffice to say here that because of the burden financially, mentally, and psychosocial of VVC and recurrent VVC, there are emerging clinical therapies on the horizon, especially in patients who feel the azole that are the first-line therapy.
Oluwatosin GojeGUEST
62:51
So in summary for Module 5, We conclude by saying that azole resistance is multifactorial.
Oluwatosin GojeGUEST
61:51
We talked about what is emerging and what is on the horizon.
Oluwatosin GojeGUEST
61:57
Preclinical and emerging approaches to VVC includes the use of vaccines, biofilm-disrupting agents, niclosamide nanoparticles, pH-responsive MOFs, designed antimicrobial peptides, and molecular resistance testing.
Oluwatosin GojeGUEST
62:19
Suffice to say here that because of the burden financially, mentally, and psychosocial of VVC and recurrent VVC, there are emerging clinical therapies on the horizon, especially in patients who fail the azole that are the first-line therapy.
Oluwatosin GojeGUEST
62:42
So in summary, for module five, we conclude by saying that azole resistance is multifactorial.

1 more episode mentions Metal–organic framework.

Create an account to see the whole feed, search across every transcript, and follow the entities you care about.

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click “Accept All” to consent, or “Decline non-essential” to opt out of non-essential cookies. Read our Privacy Policy.